News Tysabri failure in stroke a setback for Biogen Biogen’s hopes that one of its established multiple sclerosis drugs might also help stroke sufferers have been dashed.
Views & Analysis The future of stroke treatment Stroke is a major cause of disability and death worldwide and the third most common cause of death in developed countries. Nearly six million people die from stroke every year and another five million are left permanently disabled.
News Stroke prevention device wins healthtech award Neuravi's Embotrap II can clear blood clots responsible for stroke.
News Virtual reality stroke rehab platform gets FDA clearance MindMotion Pro helps with upper-limb rehabilitation following a stroke.
News Biogen pays Remedy $120m to bolster stroke pipeline Acquisition provides Biogen a fall back molecule in this high risk therapy area.
News IBM Watson to bring AI to brain bleed detection Five-year deal aims to reduce misdiagnosis of brain bleeds caused by trauma or stroke.
News Neuralink rival Precision raises $102m, and other financings Neuralink rival Precision Neurosciences raises $102m for its brain-computer interface tech, plus financings for Redesign, DeepLife, TG0 and Tuva.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
